, /PRNewswire/ -- , a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today announced that longtime healthcare executive has been named the company's new CEO. , who has served as CEO since 2021, will continue to serve as Chairman and President of Sysmex America with a focus on the company's emerging hinotoriTM Surgical Robotic System business. Dan is a diagnostics industry executive with more than 33 years of experience.
He has worked at Roche for the last 24 years, most recently as senior vice president of commercial operations, successfully leading the company to achieve its number one position in the U.S. market.
Dan has also held several global sales and marketing leadership positions and served as national director of sales and marketing for Roche Canada and as a regional business manager in the northeast territory. Before joining Roche, he worked in sales at Pharmacia Dx, Sanofi (now part of Beckman), Bio-Rad and Chiron (now part of Siemens). "It's an honor to join Sysmex America, a trusted global leader respected for optimizing the efficiency, operations and financial performance of clinical laboratories," says .
"As the healthcare landscape transforms from volume to value, Sysmex America will have more opportunities to further its commitment to equipping patients and the healthcare professionals who treat them with the information needed to make decisions with greater trust and confidence. My fo.